www.fda.gov Open in urlscan Pro
2a02:26f0:1700:189::2e60  Public Scan

Form analysis
2 forms found in the DOM

Name: searchForm — GET /search

<form class="fda-masthead__search sr-only" role="search" action="/search" method="GET" name="searchForm" id="search-form" accept-charset="UTF-8">
  <div class="search-popover" id="search-popover">
    <div class="input-group pull-right" id="search-group">
      <label class="sr-only" for="search-query">Search FDA</label>
      <input class="form-control search-input" id="search-query" name="s" aria-autocomplete="list" aria-haspopup="true" title="Enter the terms you wish to search for." placeholder="Search FDA" type="text">
      <span class="input-group-btn" id="input-group-btn">
        <button type="submit" class="btn btn-danger search-btn" id="search-btn" title="Search"><span class="fa fa-search" aria-hidden="true"><span class="sr-only">Submit search</span></span></button>
      </span>
    </div>
  </div>
</form>

POST https://public.govdelivery.com/accounts/USFDA/subscribers/qualify

<form class="form-horizontal" id="GD-snippet-form" action="https://public.govdelivery.com/accounts/USFDA/subscribers/qualify" accept-charset="UTF-8" method="post">
  <input name="utf8" type="hidden" value="✓">
  <input type="hidden" name="authenticity_token" value="VJuyc1HyD63+xVCkN+K9qiH1bD9zSSJ+BfdR1d4LXjZ0BncrJ/u9dEw/e0U869OeCw6JxhyYXfnZCCGNF1oVkQ==">
  <input type="hidden" name="topic_id" id="topic_id" value="USFDA_390">
  <label class="sr-only" for="email">Enter your email address to subscribe:</label>
  <div class="input-group subscribe-group">
    <input type="email" name="email" id="email" placeholder="Email Address" class="form-control">
    <span class="input-group-btn"><input class="btn btn-primary" type="submit" name="commit" value="Subscribe"></span>
  </div>
</form>

Text Content

 * Skip to main content
 * Skip to FDA Search
 * Skip to in this section menu
 * Skip to footer links

An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive
information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that
any information you provide is encrypted and transmitted securely.


U.S. FOOD AND DRUG ADMINISTRATION

 *   Search
 *   Menu

Search FDA Submit search


FEATURED

 * Contact FDA
 * FDA Guidance Documents
 * Recalls, Market Withdrawals and Safety Alerts
 * Press Announcements
 * Warning Letters
 * Advisory Committees
 * En Español


PRODUCTS

 * Food
 * Drugs
 * Medical Devices
 * Radiation-Emitting Products
 * Vaccines, Blood, and Biologics
 * Animal and Veterinary
 * Cosmetics
 * Tobacco Products


TOPICS

 * About FDA
 * Combination Products
 * Regulatory Information
 * Safety
 * Emergency Preparedness
 * International Programs
 * News and Events
 * Training and Continuing Education
 * Inspections and Compliance
 * Science and Research


INFORMATION FOR

 * Consumers
 * Patients
 * Industry
 * Health Professionals
 * Federal, State and Local Officials


In this section: Vaccines, Blood & Biologics
 * Vaccines
    * Emergency Use Authorization for Vaccines Explained
    * Approved Vaccine Products
    * Questions about Vaccines
   
   

 1. Home
 2. Vaccines, Blood & Biologics
 3. Vaccines

 1. Vaccines, Blood & Biologics


VACCINES

Subscribe to Email Updates
 * Share
 * Tweet
 * Linkedin
 * Email
 * Print


Image


Vaccines, as with all products regulated by FDA, undergo a rigorous review of
laboratory and clinical data to ensure the safety, efficacy, purity and potency
of these products. Vaccines approved for marketing may also be required to
undergo additional studies to further evaluate the vaccine and often to address
specific questions about the vaccine's safety, effectiveness or possible side
effects.

According to the Centers for Disease Control and Prevention, vaccines have
reduced preventable infectious diseases to an all-time low and now few people
experience the devastating effects of measles, pertussis and other illnesses.

The Center for Biologics Evaluation and Research (CBER) regulates vaccine
products. Many of these are childhood vaccines that have contributed to a
significant reduction of vaccine-preventable diseases.


VACCINE INFORMATION

 * Emergency Use Authorization for Vaccines Explained
 * Biologics License Applications (BLA) Process (CBER)
 * CDC National Immunization Program
 * Questions about Vaccines
 * Vaccines and Related Biological Products Advisory Committee
 * Vaccine and Related Biological Product Guidances
 * Vaccines Licensed for Use in the United States
 * Vaccine Notices, Proposed and Final Rules


VACCINE SAFETY & AVAILABILITY

 * Common Ingredients in U.S. Licensed Vaccines
 * Vaccine Adverse Events
 * Vaccine Safety & Availability
 * Influenza Virus Vaccine Safety & Availability
 * Vaccine Safety Questions and Answers
 * Recommendations for the Use of Vaccines Manufactured with Bovine-Derived
   Materials
 * Thimerosal in Vaccines
 * MMWR - Guillain-Barre Syndrome Among Recipients of Menactra Meningococcal
   Conjugate Vaccine
 * Vaccines for Use During Pregnancy to Protect Young Infants from Disease -€“
   FDA Update


MEDICAL COUNTERMEASURES

 * Anthrax
 * Smallpox
 * Key Facts About Vaccines to Prevent Monkeypox Disease


PANDEMIC

 * Update: COVID-19 Vaccine Booster Composition
 * Memorandum Re: Fall 2022 COVID-19 Vaccine Strain Composition Selection
   Recommendation
 * Pandemic Influenza Information


SEASONAL INFORMATION

 * Is It a Cold or the Flu? Prevention, Symptoms, Treatments
 * Influenza Virus Vaccine Safety & Availability

--------------------------------------------------------------------------------


RELATED INFORMATION

 * Vaccines and Related Biological Products Advisory Committee
 * Vaccine and Related Biological Product Guidances
 * Vaccine Notices, Proposed and Final Rules
 * Vaccines Research


Sub-Topic Paragraphs


FOLLOW CBER

Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Center for Biologics Evaluation and Research
Food and Drug Administration
10903 New Hampshire Ave WO71-3103
Silver Spring, MD 20993-0002




ocod@fda.hhs.gov



(800) 835-4709
(240) 402-8010



For Updates on Twitter, follow @fdacberExternal Link Disclaimer

 * Resources for You (Biologics)
 * About the Center for Biologics Evaluation and Research (CBER)
 * Report a Problem to the Center for Biologics Evaluation & Research
 * Recalls (Biologics)
 * CBER-Regulated Products: Shortages and Discontinuations
 * Biologics Products & Establishments



   CONTENT CURRENT AS OF:
   
   08/18/2022


 * REGULATED PRODUCT(S)
   
    * Biologics
    * Vaccines

 * Vaccines
    * Emergency Use Authorization for Vaccines Explained
    * Approved Vaccine Products
    * Questions about Vaccines
   
   


SUBSCRIBE FOR CBER UPDATES

Get e-mail updates on What’s New at CBER!

Enter your email address to subscribe:



FOOTER LINKS

 * FDA Archive
 * About FDA
 * Accessibility

 * Visitor Information
 * Website Policies / Privacy
 * No FEAR Act
 * Vulnerability Disclosure Policy

 * FOIA
 * HHS.gov
 * USA.gov

Contact FDA Follow FDA on Facebook Follow FDA on Twitter View FDA videos on
YouTube Subscribe to FDA RSS feeds
FDA Homepage
Contact Number 1-888-INFO-FDA (1-888-463-6332)

Back to Top